Scholars Central

Conference abstractPublished 2018

Biosimilars: Why are they so widely misunderstood?

Authors: Sarfaraz K Niazi

Karyo Biologics, LLC and Pharmaceutical Scientist Inc., USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Biological drugs coming off patent can be presented as biosimilars, not as generics because of inherent variability in lot-to-lot variability. Matching similarity is like tracking a moving target requiring a deeper understanding that is often missed. All rejections of biosimilar applications by the FDA have come from lack of sufficient similarity across wide variability. First, there is no phase 1 of phase 3 studies involved; these are clinical pharmacology and additional clinical studies to prove non-inferiority. If a product had to be taken to test into patients, then it is not a very good match with the originator molecule—the idea is to obviate, not encourage studies in patients. Non-inferiority statistical is the only type of testing required, requiring a different experimental design than used in developing new biologics. The science of matching a molecular structure only comes to play in the case of biosimilars—an art and science that is not widely practiced, slowing down entry of biosimilars. A good example of these failures can be seen in the rejections of applications by FDA, from major companies with every conceivable resource in their hands—they just failed to follow a stepwise approach. Providing clinical safety data in patients does not overcome any structural differences.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nephrology & Renal Diseases.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nephrology & Renal Diseases
  • SubjectNephrology & Urology
  • BylineArticles whose byline prints “Sarfaraz K Niazi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels